Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Identification of API by IR Spectroscopy – V 2.0

Posted on By

Elixir Department: SOP for Identification of API by IR Spectroscopy – V 2.0

Standard Operating Procedure for Identification of Active Pharmaceutical Ingredient (API) by IR Spectroscopy

Department Elixir Department
SOP No. SOP/ELX/213/2025
Supersedes SOP/ELX/213/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for the identification of Active Pharmaceutical Ingredients (APIs) in elixir formulations using Infrared (IR) Spectroscopy. This ensures reliable and accurate confirmation of API identity as per pharmacopeial standards.

2. Scope

This SOP applies to all quality control analysts performing identification of APIs by IR spectroscopy for raw materials, intermediate samples, and finished elixir products in the Elixir Department.

3. Responsibilities

  • QC Analyst:
    • Prepare samples and standard, operate the IR spectrophotometer, and document spectra.
  • QC Supervisor:
    • Verify the comparison of sample spectra with reference spectra and ensure data integrity.
  • QA Officer:
    • Review and approve results as part of batch release process.

4. Accountability

The QC Head is accountable for ensuring the IR method is validated and properly executed. QA is responsible for the final verification of identity test records.

See also  Elixir Department: SOP for Minimizing Foaming During Mixing - V 2.0

5. Procedure

5.1 Instrument Preparation

  1. Ensure the IR spectrophotometer (FTIR or dispersive) is clean, calibrated, and switched on for at least 30 minutes before use.
  2. Verify background scan is performed and saved prior to analysis.
  3. Use desiccated potassium bromide (KBr) or ATR (Attenuated Total Reflectance) setup as per method.

5.2 Preparation of Reference Standard

  1. Dry the API reference standard if required (as per method).
  2. Grind with dry KBr in a 1:100 ratio and press into a transparent pellet using a pellet press (if KBr method is used).
  3. If using ATR, place the pure standard on the crystal and scan directly.

5.3 Preparation of Test Sample

  1. Take a portion of dried API or extract API from elixir matrix if required (as per method).
  2. Prepare KBr pellet or use ATR method, ensuring no contamination.
See also  Elixir Department: SOP for Use of Transfer Pumps in Manufacturing - V 2.0

5.4 IR Spectral Scan

  1. Place sample or pellet in sample holder/ATR plate.
  2. Run the scan in the IR range of 4000 to 400 cm⁻¹.
  3. Record the spectra and overlay with the standard/reference spectra.

5.5 Interpretation and Acceptance Criteria

  1. Compare characteristic peaks (e.g., functional group region, fingerprint region).
  2. The sample must show matching peaks within ±2 cm⁻¹ of the standard spectrum.
  3. No additional or missing peaks should be observed in the sample spectrum.

5.6 Documentation

  1. Save and print the IR spectra of standard and sample.
  2. Record test details in the IR Identification Logbook (Annexure-1).
  3. Attach the spectra and result summary in the batch file or analytical worksheet.

5.7 Precautions

  1. Use clean and dry equipment for pellet preparation.
  2. Do not touch KBr pellets with bare hands.
  3. Ensure desiccator storage of KBr powder and pellets to prevent moisture interference.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • IR: Infrared
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • KBr: Potassium Bromide
  • ATR: Attenuated Total Reflectance
See also  Elixir Department: SOP for Test for Suspended Particles - V 2.0

7. Documents

  1. IR Identification Logbook (Annexure-1)
  2. Instrument Calibration Certificate
  3. Batch Manufacturing Record (BMR)

8. References

  • USP General Chapter <197K> – Identification by Infrared Spectroscopy
  • 21 CFR Part 211.165 – Testing and Release for Distribution
  • ICH Q2(R1) – Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IR Identification Logbook

Date Batch No. Sample ID Method Used Result Tested By Checked By
11/04/2025 ELX-0425-031 API-A USP IR Method Complies Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Added ATR method and precautions for sample prep Method Update QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: SOP for Execution of Method Transfer Studies – V 2.0
Next Post: Audit Risks from Delayed Closure of Change Control Records

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version